Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country SII ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback